Sheryl L. Meyer - Concepedia

Concepedia

Author

Sheryl L. Meyer

Albert Einstein College of Medicine

Also Known As

S Meyer, S. Meyer, S.L Meyer, S.L. Meyer, Sheryl L. MEYER, Sheryl L. Meyer, Sheryl Lynne Meyer, Sheryl Meyer

38

Publications

1.2K

Citations

19

H-Index

52

Concepts

All Affiliations

Albert Einstein College of Medicine Yeshiva University Brandywine Photonics (United States)Worldwide Clinical Trials (United States)Weizmann Institute of Science

SL

About

Sheryl L. Meyer is an author at Albert Einstein College of Medicine specializing in medicine, biochemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	401
2	Biochemistry	6	6	305
3	Natural Sciences	4	4	250
4	Cell Biology	4	4	122
5	Biomolecular Engineering	1	1	10

Sheryl L. Meyer

×

24

Publications

1.2K

Citations

19

H-Index

	Year	Citations
CEP-1347 (KT7515), a Semisynthetic Inhibitor of the Mixed Lineage Kinase Family Anna C. Maroney, James P. Finn, Thomas J. Connors, Journal of Biological Chemistry	2001	204
Characterization and preliminary attempts for derivatization of crystals of large ribosomal subunits from Haloarcula marismortui diffracting to 3 Å resolution K. von Böhlen, I. Makowski, Harly A. S. Hansen, Journal of Molecular Biology X-ray CrystallographyHalogenationBiosynthesisBiochemistryNatural Sciences	1991	129
Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells Weihua Wan, Mark S. Albom, Lihui Lü, Blood	2005	105
Inosine−Uridine Nucleoside Hydrolase from <i>Crithidia fasciculata</i>. Genetic Characterization, Crystallization, and Identification of Histidine 241 as a Catalytic Site Residue<sup>,</sup> Deshmukh N. Gopaul, Sheryl L. Meyer, Massimo Degano, Biochemistry	1996	89
A New Class of Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Structure−Activity Relationships for a Series of 9-Alkoxymethyl-12-(3-hydroxypropyl)indeno[2,1-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole-5-ones and the Identification of CEP-5214 and Its Dimethylglycine Ester Prodrug Clinical Candidate CEP-7055 Diane E. Gingrich, D. Rajagopala Reddy, Mohamed Iqbal, Journal of Medicinal Chemistry PharmacotherapyMedicinal ChemistryAngiogenesisFibroblast Growth FactorTyrosine Kinase Inhibitors	2003	74
A Selective, Orally Bioavailable 1,2,4-Triazolo[1,5-<i>a</i>]pyridine-Based Inhibitor of Janus Kinase 2 for Use in Anticancer Therapy: Discovery of CEP-33779 Benjamin J. Dugan, Diane E. Gingrich, Eugen F. Mesaros, Journal of Medicinal Chemistry	2012	62
Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system Sheryl L. Meyer, Donna Bozyczko‐Coyne, Satish Mallya, Biochemical Journal	1996	57
Characterization of AMD, the AMP deaminase gene in yeast. Production of amd strain, cloning, nucleotide sequence, and properties of the protein Sheryl L. Meyer, Kalla Kvalnes-Krick, Vern L. Schramm Biochemistry	1989	49
Subsite requirements for peptide aldehyde inhibitors of human calpain I Mohamed Iqbal, Patricia A. Messina, Bethany Freed, Bioorganic & Medicinal Chemistry Letters Aldo-keto ReductaseBiochemistryMedicinePeptide LibraryBioanalysis	1997	44
BDNF and NT4/5 promote survival and neurite outgrowth of pontocerebellar mossy fiber neurons Sylvia A. Rabacchi, Barbara Kruk, Jason A. Hamilton, Journal of Neurobiology	1999	44

Page 1